Reviva Pharmaceuticals Holdings, Inc. (OTC:RVPH) appeared in the 13F filings of 5 institutional investors for the quarter ended June 30, 2026.
Their combined stake equaled 0.06% of outstanding shares in Q2 2026, down from 22.80% in Q1 2026.
Total holdings of RVPH shares fell 99.74% from Q1 2026, and the holder count fell 89.13% from Q2 2025.
Among the 5 holders of Reviva Pharmaceuticals Holdings, 3 added to their positions and 2 left their positions unchanged.
In total, institutional investors held 7.73K shares of Reviva Pharmaceuticals Holdings at the end of Q2 2026, down 2.91Mn from the prior quarter and down 706.58K from a year earlier.
As of June 30, 2026, the biggest holder of Reviva Pharmaceuticals Holdings was EMC Capital Management with 6.7K shares, or 0.05% of shares outstanding.
Per Business Quant, the top 5 investors in RVPH for the quarter ended June 30, 2026 were EMC Capital Management (6.7K shares), TD Waterhouse Canada Inc. (625 shares), Purpose Unlimited Inc. (405 shares), Mosley Wealth Management (1 share) and Miller Global Investments, LLC (1 share).